Cancer Immunotherapeutic Potential of Novel Small Molecule TLR7 and TLR8 Agonists

Journal of Immunotoxicology - United States
doi 10.3109/15476910903286733
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Informa UK Limited

Related search

Small Molecule Follicle-Stimulating Hormone Receptor Agonists and Antagonists

Frontiers in Endocrinology
EndocrinologyMetabolismDiabetes
2019English

New Small Molecule Agonists to the Thyrotropin Receptor

Thyroid
MedicineEndocrinologyMetabolismDiabetes
2015English

TLR7 Deficiency Leads to TLR8 Compensative Regulation of Immune Response Against JEV in Mice

Frontiers in Immunology
AllergyImmunology
2017English

Therapeutic Potential of a Novel Small Molecule in Modifying Lumbar Disc Degeneration

Osteoarthritis and Cartilage
Sports MedicineRheumatologyOrthopedicsBiomedical Engineering
2019English

Conjugation of a Small-Molecule TLR7 Agonist to Silica Nanoshells Enhances Adjuvant Activity

English

Novel Small-Molecule Inhibitors of BCL-Xl to Treat Lung Cancer

Cancer Research
Cancer ResearchOncology
2013English

Specific Activation of the TLR1-TLR2 Heterodimer by Small-Molecule Agonists

Science advances
Multidisciplinary
2015English

Development of Functionally Selective, Small Molecule Agonists at Kappa Opioid Receptors

Journal of Biological Chemistry
BiochemistryCell BiologyMolecular Biology
2013English

Investigation of TRPM4 in Prostate Cancer Cells With Novel Small Molecule Inhibitors

Biophysical Journal
Biophysics
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy